Myltega 50mg Tablet 30s

Introduction to Myltega 50mg Tablet 30s

Myltega 50mg Tablet 30s is a medication primarily used to treat HIV, a virus that attacks the immune system. This tablet form of medicine helps control the infection by preventing the virus from replicating, thereby improving immune function.

Composition of Myltega 50mg Tablet 30s

The active ingredient in Myltega 50mg Tablet 30s is Dolutegravir. Dolutegravir is an antiretroviral medication that works by inhibiting the integrase enzyme, which the HIV virus uses to integrate its genetic material into human DNA. This action prevents the virus from replicating and spreading.

Uses of Myltega 50mg Tablet 30s

• Treatment of HIV infection
• Improvement of immune function

Side effects of Myltega 50mg Tablet 30s

• Common side effects: headache, insomnia, fatigue
• Serious side effects: potential liver problems, especially in individuals with hepatitis B or C

Precautions of Myltega 50mg Tablet 30s

Dolutegravir, the active ingredient in Myltega 50mg Tablet 30s, may increase the risk of neural tube defects if taken during early pregnancy. It is also important to monitor liver function, particularly in patients with hepatitis B or C.

How to Take Myltega 50mg Tablet 30s

The usual starting dose of Myltega 50mg Tablet 30s for adults is 50 mg once daily. It can be taken with or without food. Your doctor may adjust the dosage based on your specific health needs. Always follow your doctor's instructions for the correct usage.

Conclusion of Myltega 50mg Tablet 30s

Myltega 50mg Tablet 30s, containing Dolutegravir, is an antiretroviral medication used to treat HIV infection. It belongs to the therapeutic class of integrase inhibitors and is manufactured to help improve immune function by preventing viral replication. Key highlights include its effectiveness in controlling HIV and the importance of adhering to prescribed dosages and precautions. Myltega 50mg Tablet 30s is a crucial part of HIV treatment regimens.